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The amphipathic α-helical peptide KIA14 [(KIAGKIA)2-NH2] was studied in membranes 
using circular dichroism and solid-state NMR spectroscopy, to obtain global as well as local 
structural information. By analyzing 2H-NMR data from ten analogues of KIA14 that were 
selectively labelled with Ala-d3, those positions that are properly folded into a helix could be 
determined within the membrane-bound peptide. The N-terminus was found to be unravelled, 
while positions 4-14 formed an ideal helix all the way to the C-terminus. The helicity did not 
change when Gly residues were replaced by Ala-d3, but was reduced when Ile was replaced, 
indicating that large hydrophobic residues are required for membrane binding and helix 
formation. The reduced helicity was strongly correlated with a decrease in peptide-induced 
leakage from lipid vesicles. The orientation of the short KIA14 peptide was assessed in 
several lipid systems and compared with that of the longer KIA21 sequence [(KIAGKIA)3-
NH2]. In DOPC, both peptides are aligned flat on the membrane surface, whereas in 
DMPC/lyso-MPC both are inserted into the membrane in an upright orientation. These two 
types of lipid systems had been selected for their strongly negative and positive spontaneous 
curvature, respectively. We propose that in these cases the peptide orientation is largely 
determined by the lipid properties. On the other hand, in plain DMPC and DLPC, which have 
only a slight positive curvature, a marked difference in orientation is evident: the short KIA14 
lies almost flat on the membrane surface, while the longer KIA21 is more tilted. We thus 
propose that out of the lipid systems tested here, DMPC (with hardly any curvature) is the 
least biased lipid system in which peptide orientation and re-alignment can be studied, 
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Membrane-associated peptides perform many important biological functions. Some prominent 
groups of membrane-active peptides include antimicrobial peptides (AMPs) that kill 
microorganisms by permeabilizing the cell membrane,1-3 cell-penetrating peptides that 
penetrate lipid bilayers and can carry cargo inside without killing the cells,4-5 and fusogenic 
peptides that induce cell fusion.6-8 Despite a plethora of biophysical studies that have been 
carried out on these peptides in model membranes, their diverse mechanisms of action are still 
not fully understood with respect to the respective roles of peptide properties and lipid 
properties. 
 
AMPs are found in almost all types of organisms and constitute host defence systems against 
microorganisms.1,9 Over 2000 AMPs have currently been identified.10 Linear cationic 
amphipathic α-helices are one of the most common types and have the widest antimicrobial 
activity spectrum; some typical examples include magainins from frogs11 and LL-37 from 
humans.12 We recently showed that the activity of these AMPs can be strongly dependent on 
the peptide length 13. A battery of peptides of various lengths containing the repeated basic 
sequence KIAGKIA, called KIA peptides, was designed from a subset of the antimicrobial 
PGLa from the magainin family. A systematic comparison of their membranolytic activities 
and membrane-bound structures showed that the helix must be long enough to span the 
hydrophobic region of the membrane to form pores, which are proposed to be responsible for 
function.13 
 
As a first approximation of peptide length, we assumed that the peptides form an ideal α-helix 
in which the helical rise is 1.5 Å per residue. While this is a reasonable assumption for the 
central region of the helix, it may not be true closer to the termini. Circular dichroism 
spectroscopy (CD) was used to estimate the secondary structure elements of the KIA peptides, 
and an α-helix content of 69-83% was found for this series. For example, the shortest peptide 
(KIA14, 14 amino acids) had a helicity of 74%, which corresponds to 10 amino acids, while 
and the longer peptide (KIA21, also known as MSI-103, 21 amino acids) was 83% helical, 
corresponding to 17 amino acids.14 These values suggest that approximately four residues in 
each peptide are not in a helical configuration, but it is not clear which residues are non-
helical, since CD does not provide local information. Helices are proposed to be frayed at the 
ends where the hydrogen bond pattern is not fulfilled. Because hydrogen bonds between the 
backbone atoms from position n to n+4 exist in an α-helix, the four residues closest to each 
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terminus cannot participate fully in the hydrogen bond pattern. It is therefore likely that the 
central region of the peptide is helical, while the ends may be frayed. 
 
A possible approach for experimentally detecting frayed membrane-bound peptides is to place 
a series of selective isotope-labels in the peptide and perform solid-state NMR in a membrane 
environment. From the measured NMR parameters, it is possible to find out whether and 
which of the labelled positions form an α-helix. When the data are plotted as a helical wave, 
those points that deviate from the curve can indicate fraying.15-16 2H-NMR on Ala-d3 labeled 
peptides is especially useful on peptides containing several Ala in the sequence, where the 
labeling does not change the peptide,17-19 but can also be used as an Ala scan to determine the 
effect of replacing other residues.20   
 
We have previously studied MSI-103 [(KIAGKIA)3-NH2],
21-22 which will be called KIA21 
herein to indicate similarity to KIA14, and determined its orientation in numerous lipid 
systems using 2H-NMR,23-24 The helix was found to assume different alignments depending 
on the spontaneous curvature of the lipid used. Namely, the peptide was aligned flat on the 
membrane surface in lipid bilayers with a negative spontaneous curvature (like POPC), but it 
flipped by about 30° to become obliquely inserted in membranes with a small positive 
spontaneous curvature (like DMPC).24-25 For KIA21, only the central region of the peptide 
between positions 7 and 17 had been labelled, so no fraying effects were addressed.23-24 Here, 
we present a similar study of the shorter KIA14 [(KIAGKIA)2-NH2], which was labelled with 
Ala-d3 one-by-one at every single position, except for the charged Lys residues, covering the 
entire length of the peptide from position 2 all the way to the C-terminus at position 14. By 
measuring the corresponding quadrupolar splittings with 2H-NMR and fitting all these values 
to a helical curve, we could thus obtain the detailed orientation and dynamics of the short 
KIA14 helix in the membrane. These results can now be compared with the behaviour of 
KIA21 and other previously reported peptides.17-19,23,26-31 Furthermore, by assessing the fit of 
the individual data points to that of the overall helical wave curve, we can find out whether 
residues close to the termini deviate from the ideal helix curve. This kind of analysis reveals 
the stretch in which the KIA14 peptide forms an ideal helix, and it showed how close to the 
termini this short helix exhibits frayed ends. Furthermore, the NMR data can also be 
compared with CD data to assess the global and local helicity, and with functional data from 
vesicle leakage experiments to correlate helicity with membrane activity. 
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Both KIA14 and KIA21 form α-helices and have a similar distribution of amino acids around 
the helix, with a narrow polar sector (Figure 1). While KIA21 shows high activity in terms of 
antimicrobial effects, leakage of lipid vesicles, and well as haemolysis, KIA14 is inactive, 
most likely because it is too short to span the membrane in the form of pores that cause 
leakage and can kill bacteria and erythrocytes.13 In our previous studies, we had monitored the 
membrane alignment of KIA21 and KIA14 as a function of peptide concentration, in an 
attempt to correlate membrane behaviour and biological activity.14,24 Here, we have carefully 
analysed KIA14 in four different types of model membranes so that it can be compared with 
KIA21, because lipid composition is generally known to affect the re-alignment of peptides, 
but the roles and relative contributions of hydrophobic thickness and spontaneous curvature 
are not yet fully understood. 
  
Figure 1. Helical wheel projection of KIA14 and KIA21. The hydrophobic sector is shaded. Charged 
Lys residues are indicated with boxes, and 2H-labelled positions are marked with circles. The centre of 
the polar sector is marked with an arrow. 
 
Page 5 of 37
ACS Paragon Plus Environment































































Materials and Methods 
 
Materials 
Peptide synthesis reagents and Fmoc-protected amino acids were purchased from Merck 
Biosciences (Darmstadt, Germany) and Iris Biotech (Marktredwitz, Germany). 2H-labelled 
2,2,2-2H3-L-Ala (Ala-d3) was purchased from Cambridge Isotope Laboratories (Andover, 
MA, USA), and its N-terminus was Fmoc-protected.32 Solvents were purchased from Merck 
(Darmstadt, Germany). The lipids 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine 
(DMPC), 1-myristoyl-2-hydroxy-sn-glycero-3-phosphatidylcholine (lyso-MPC), 1,2-
dimyristoleoyl-sn-glycero-3-phosphatidylcholine (DMoPC), 1,2-dimyristoleoyl-sn-glycero-3-
phosphatidylglycerol (DMoPG) 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC), and 
1,2-dilauroyl-sn-glycero-3-phosphatidylcholine (DLPC) were obtained from Avanti Polar 
Lipids (Alabaster, AL, USA). 
 
Table 1. Synthesized peptides used in the 2H-NMR analysis. The highlighted Ala-d3 was 
labeled with deuterium at the side chain methyl-group. 
Peptide Labeled 
position 








KIA14 None KIAGKIAKIAGKIA-NH2 1380.87 1381.97 
KIA14-I2A Ile-2 K-Ala-d3-AGKIAKIAGKIA-NH2 1341.78 1342.92 
KIA14-A3 Ala-3 KI-Ala-d3-GKIAKIAGKIA-NH2 1383.87 1384.97 
KIA14-G4A Gly-4 KIA-Ala-d3-KIAKIAGKIA-NH2 1397.89 1398.99 
KIA14-I6A Ile-6 KIAGK-Ala-d3-AKIAGKIA-NH2 1341.78 1342.92 
KIA14-A7 Ala-7 KIAGKI-Ala-d3-KIAGKIA-NH2 1383.87 1384.96 
KIA14-I9A Ile-9 KIAGKIAK-Ala-d3-AGKIA-NH2 1341.78 1342.92 
KIA14-A10 Ala-10 KIAGKIAKI-Ala-d3-GKIA-NH2 1383.87 1384.96 
KIA14-G11A Gly-11 KIAGKIAKIA-Ala-d3-KIA-NH2 1397.89 1398.95 
KIA14-I13A Ile-13 KIAGKIAKIAGK-Ala-d3-A-NH2 1341.78 1342.91 
KIA14-A14 Ala-14 KIAGKIAKIAGKI-Ala-d3-NH2 1383.87 1384.96 
a Theoretical molecular weight in g/mol  
b MALDI-TOF m/z, [M + H]+ 
 
Peptide synthesis 
Peptides were synthesized on a fully automated parallel peptide synthesizer (Syro II, 
MultiSynTech GmbH, Witten, Germany) using standard solid phase Fmoc protocols, as 
previously reported.33 In each peptide analogue, a single residue was replaced with Ala-d3. A 
list of the peptides and the Ala-d3 positions in each instance is provided in Table 1. The crude 
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material was purified by high-performance liquid chromatography (HPLC) on a Vydac C18 
column using an acetonitrile/water gradient supplemented with 5 mM HCl. The product 
identities were confirmed by observing a single peak on an analytical liquid chromatography 
system (Agilent 1100 series, Santa Clara, CA, USA) connected to a µTOF (time-of-flight) 
mass spectrometer (Bruker Daltonics, Bremen, Germany), and they were shown to be at least 
95% pure. 
 
Vesicle leakage assay 
Samples for fluorescence leakage experiments were prepared by entrapping the fluorophore 
ANTS and the quencher DPX within large unilamellar vesicles, as previously described.34-36 
ANTS (12.5 mM) and DPX (45 mM) were mixed together in 50 mM NaCl and 10 mM 
HEPES (pH 7.5) to prepare the buffer solution. Liposomes were prepared by co-dissolving 
DMoPC/DMoPG (1/1 mol/mol) lipids in CHCl3/MeOH (1/1 v/v), together with 0.1 mol% 
Rhodamine-PE, by which the lipid loss during vesicle preparation and purification could be 
quantified. The lipid mixture was dried under nitrogen flow for 30-60 min, followed by 
vacuum overnight. Buffer solution was added to the falcon tube, and the lipid film was re-
suspended by vigorous vortexing, followed by 10 freeze(liquid N2)-thaw(37°C)-vortex 
cycles.37 Large unilamellar vesicles (LUVs) were obtained by 41-fold extrusion (Avanti Mini 
Extruder; Avanti Polar Lipids, Alabaster, AL) of the liposomes through a nuclepore 
polycarbonate membrane (pore size 100 nm, Whatman - GE Healthcare Europe, Freiburg, 
Germany) at room temperature. Unencapsulated ANTS and DPX were separated from the 
entrapped material by gel filtration, using spin columns filled with Sephacryl 100-HR (Sigma-
Aldrich, Taufkirchen, Germany) and initially equilibrated with an elution buffer (150 mM 
NaCl, 10 mM HEPES, pH 7.5) that balances the internal vesicle osmolarity. This purification 
was done before every measurement. Leakage of encapsulated ANTS was monitored by 
fluorescence dequenching of ANTS.38 Fluorescence measurements were performed in a 
thermostated cuvette with constant stirring at 30 ºC in the same buffer as for gel filtration. A 
FluoroMax2 spectrofluorimeter (HORIBA Jobin Yvon, Unterhaching, Germany) was used, 
setting the ANTS emission to 510 nm (5 nm slit) and its excitation to 355 nm (5 nm slit). The 
exact volume of vesicle solution needed for a final lipid concentration of 100 µM was 
calculated, based on the Rhodamine (Rhod-PE) maximum fluorescence intensity of the 
prepared vesicles in comparison to the initial vesicles (before extrusion and purification). The 
peptides were solubilized in water at a concentration of 150 µM (stock solution). For the 
leakage experiment, peptides were added to the cuvette containing the vesicles at the P/L ratio 
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to be tested, and fluorescence was monitored for 10 min. After 10 min, 0.25 vol% Triton X-
100 was added to obtain the fluorescence value corresponding to 100% leakage. The level of 
0% leakage corresponded to the fluorescence of the vesicles after 10 min in a reference 
sample without peptide. 
 
Circular dichroism spectropolarimetry (CD) 
CD samples were prepared by co-solubilizing DMPC and DMPG (3:1 mol/mol) in 
chloroform/methanol (3:1 v/v). After drying, the lipid film was dispersed in phosphate buffer 
(10 mM, pH 7) and homogenized by 10 freeze–thaw cycles with vigorous vortexing after each 
cycle. Small unilamellar vesicles (SUVs) for CD samples were generated by sonicating for 16 
min in an ultrasonic bath (UTR 200, Hielscher, Germany) at 35°C (above the phase transition 
of the lipids). CD spectra were recorded on a J-815 spectropolarimeter (JASCO, Groß-
Umstadt, Germany) between 260 and 185 nm at 0.1 nm intervals using 1 mm quartz glass 
cells (Suprasil, Hellma Analytics, Müllheim Germany) as previously reported 39. The peptides 
were measured at 25°C in 10 mM sodium phosphate buffer (pH 7.0) and at 30°C in lipid 
vesicles composed of DMPC/DMPG (3:1). The average baseline of the pure solvent was 
subtracted. The typical peptide concentration of the final samples was 0.1 mg/mL, and a 
peptide-to-lipid molar ratio (P/L) of 1:50 was used. 
 
Secondary structure estimation from CD spectra was performed as previously described,20 
using tools provided by the DICHROWEB online server.40-47 
 
Solid-state NMR 
Macroscopically oriented NMR samples were prepared using 0.5-0.8 mg of peptide and 
appropriate amounts of lipids to obtain samples with P/L = 1:20 or P/L = 1:50. The peptides 
and lipids were co-dissolved in 400 µL of chloroform/methanol (1:1 v/v) and spread onto 23 
thin glass plates of the dimensions 9 mm × 7.5 mm × 0.08 mm (Marienfeld Laboratory 
Glassware, Lauda-Königshofen, Germany). The plates were air-dried for 1 h and then 
vacuum-dried overnight. They were stacked and placed into a hydration chamber with 96% 
relative humidity at 48°C for 18–24 h before being wrapped in parafilm and plastic foil for the 
NMR measurements. 
 
All NMR measurements were carried out on a Bruker Avance 500 or 600 MHz spectrometer 
(Bruker Biospin, Karlsruhe, Germany) at 308 K. 31P-NMR was used to evaluate the lipid 
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orientation quality in the samples using a Hahn echo sequence with phase cycling48 and 1H 
decoupling. 200 Hz line broadening was applied to the spectra. 2H-NMR experiments were 
performed using a quadrupole echo sequence49 with a 90° pulse of 4.5 µs, an echo delay of 70 
µs, a 100-ms relaxation delay time, a 500-kHz spectral width, and 2048 data points. A total of 
100.000 to 1.000.000 scans were collected. The oriented samples were placed in a flat coil 
probe such that the lipid bilayer normal was aligned parallel to the magnetic field. 200-1000 
Hz line broadening was applied to the spectra to improve signal to noise, adapted to the 
sharpness of peaks to avoid a loss of resolution. 
 
NMR data analysis 
The orientation of a helical peptide in a membrane can be defined by two angles, the tilt angle 
τ, defined as the angle between the long axis of the helix and the membrane normal, and the 
azimuthal rotation angle ρ, which defines the rotation of the peptide around its long axis. 
Using 2H-NMR data from the Ala-d3-labelled positions, the helix orientation was calculated 
from RMSD fits and quadrupolar wave plots as previously described.17,19,27,50 
 
To calculate orientational constraints from the NMR data, a quadrupole coupling constant 
(e2qQ/h) of 167 kHz for an aliphatic C-D bond was used, giving a maximum quadrupolar 
splitting of 84 kHz for the CD3 groups of the Ala-d3 labels.
51 Thus, the quadrupolar splitting 
(∆νq) is given by 
 
∆νq = 84 kHz × ½〈3 cos
2θ – 1〉         (1) 
 
where 〈 〉 represent the time average, and θ represents the angle between the C-CD3 bond and 
the external magnetic field B0. 
 
The KIA14 peptide was modelled as an ideal α-helix, and alignment of this helix was fit to 
the orientational constraints. In the molecular frame, the tilt angle τ defines the angle between 
the helix axis (defined from the N- to the C-terminus) and the bilayer normal. The azimuthal 
angle ρ is defined as a right-handed rotation around the helix axis, where ρ = 0° indicates (by 
our definition) that a radial vector from the helix axis to the Cα atom at position 12 is oriented 
parallel to the membrane surface.50,52 Orientation of the Cα-Cβ bond in the molecular frame is 
defined by the angle β, the angle between the bond vector and the helix axis; the angle α, 
which is defined by the vector radiating from the helix axis through the Cα atom; and the 
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projection of the Cα-Cβ bond vector onto a plane perpendicular to the helix. In the same plane, 
the rotational angle between two consecutive amino acids along the helix is called ω. We use 
for an α-helix angular values of β = 121.1°, α = 53.2°, and ω = 100°, as determined from an α-
helical polyalanine model constructed in SYBYL (Tripos, St. Louis, MO, USA) based on the 
torsion angles φ = -58° and ψ = -47°.52 
 
Peptide dynamics are described as Gaussian distributions of τ and ρ angles, with widths given 
by the standard deviations στ and σρ, respectively. Larger widths correspond to a more 
dynamic situation in which the helix undergoes whole-body fluctuations with larger 
amplitude. These fluctuations are assumed to be fast on the NMR time scale so that the 
measured splittings represent time averages over these distributions.27,53 Using a grid search to 
find the best-fit peptide structure, the helix is systematically rotated, and the theoretical 
quadrupole splittings are calculated for different combinations of τ, ρ, στ and σρ. All 
parameters are changed in 1° steps; τ and ρ are examined from 0 to 180° (due to symmetry), 
and στ and σρ are investigated from 0 to 50°. These ranges have been established as being 
large enough to include the solution with the lowest root-mean-square deviation (RMSD) 
between calculated and experimental data. This best-fit combination of parameters is 
identified as providing the most likely orientation and dynamics of the peptide in the 
membrane. 
 
By evaluating the deviation between the best-fit curve and individual data points, it is possible 
to determine whether a specific labelled residue is part of the helical region of the peptide and 
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KIA14 and ten analogues in which Ala-d3 was inserted at various positions within the 
sequence (replacing all residues except for the four charged Lys residues) were successfully 
synthesized and purified. The peptides are listed in Table 1. 
 
Vesicle leakage assay 
In previous studies of KIA peptides of different length, no antimicrobial nor hemolytic effect 
was found for the short KIA14 peptide. Neither did we observe any KIA14-induced vesicle 
leakage in lipid systems with a hydrophobic membrane thickness that was greater than the 
length of this short helix (estimated to be 21 Å, from the known length of 1.5 Å per residue of 
an ideal α-helix). Only in DMoPC/DMoPG, with a hydrophobic thickness of 19 Å, did KIA14 
induce leakage.13,36 To investigate whether the Ala-d3 mutations had any influence on the 
activity of the peptide, leakage of KIA14 and its Gly→Ala-d3 and Ile→Ala-d3 mutants was 
monitored at P/L=1:100 and 1:200. As seen in Table 2, the Gly→Ala-d3 mutants exhibited 
higher activity, whereas the Ile→Ala-d3 mutants showed much less leakage than the parent 
peptide. At P/L=1:100, KIA14, KIA14-G4A and KIA14-G11A gave close to 100% leakage, 
while the Ile→Ala-d3 mutants produced only 13-21% leakage. 
 
Table 2. Leakage of DMoPC/DMoPG (1:1) vesicles induced by KIA14 and its Ala-d3 
mutants. The average and standard deviation calculated from at least three measurements for 
each peptide are shown. 
Peptide 
Leakage (%)  
P/L=1:200 
Leakage (%)  
P/L=1:100 
KIA14 65 ± 5 92 ± 2 
KIA14-I2A 15 ± 3 21 ± 1 
KIA14-G4A 78 ± 3 100 
KIA14-I6A 12 ± 3 16 ± 1 
KIA14-I9A 13 ± 1 18 ± 2 
KIA14-G11A 95 ± 3 100 




CD provides information about the secondary structure of peptides. The CD spectra of KIA14 
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and the mutants in which Gly or Ile had been replaced by Ala-d3, were measured in phosphate 
buffer, and all peptides showed random coil spectra (Figure 2A). Measurements were also 
performed in DMPC/DMPG (3:1) vesicles, and all peptides gave CD spectral shapes typical 
of an α-helical structure (Figure 2B). When the spectra were deconvoluted to determine the 
fraction of secondary structure elements as previously described,20 a highly variable amount 
of α-helical content was observed (Table 3). The original KIA14 peptide and the Gly→Ala 
mutants are approximately 75% helical. However, the Ile→Ala mutants are found to be only 
40-52% helical, which indicates that the large hydrophobic Ile residues are required to 
stabilize the helical fold in a membrane environment. For the 14-residue sequence (with 13 
peptide bonds) these numbers mean that in KIA14, KIA14-G4A and KIA14-G11A about 10 
peptide bonds participate in an α-helical conformation, while the Ile→Ala mutants have only 
6-7 helical residues. KIA14-I9A shows the highest helicity amongst these mutants, which 
suggests that the central region of the peptide is most stable as a helix, while the termini 
become more readily unfolded when Ile is replaced by Ala-d3.  
 
 
Figure 2. Circular dichroism spectra of KIA14 and the mutants in 10 mM phosphate buffer at 25°C 
(A) and in the presence of DMPC/DMPG (3:1) vesicles at P/L = 1:50 and 30°C (B). 
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Table 3. Percentages of secondary structure in KIA14 and its Ala-d3 mutants in the presence 






strand Turns Unordered Total 
KIA14 76 ± 4 4 ± 2 5 ± 2 14 ± 4 99 
KIA14-I2A 43 ± 4 13 ± 1 20 ± 3 25 ± 3 101 
KIA14-G4A 73 ± 8 5 ± 1 8 ± 3 15 ± 7 101 
KIA14-I6A 40 ± 2 13 ± 2 18 ± 3 29 ± 2 100 
KIA14-I9A 52 ± 3 13 ± 1 16 ± 1 19 ± 3 100 
KIA14-G11A 76 ± 6 4 ± 1 6 ± 2 14 ± 5 100 
KIA14-I13A 45 ± 3 12 ± 3 18 ± 1 25 ± 4 100 
a Secondary structure estimation from CD spectra was performed using the CDSSTR program with the 
implemented singular value decomposition (SVD) algorithm,40-41 using the CONTIN-LL program that 
is based on the ridge regression algorithm,42-43 and the SELCON-3 program that incorporates the self-
consistent method together with the SVD algorithm to assign protein secondary structure.44-45 The 
three algorithms are provided by the DICHROWEB on-line server.46-47 The secondary structure 
fractions of each sample were calculated as the average value of the individual percentages obtained 
with the three algorithms. As error estimate is given the standard deviation of the three values from the 
three algorithms. Individual values were not considered for the average when the sum of all structural 
elements fractions was <99% or >102%, or when the NMRSD (normalized root mean square 
deviation) between the experimental and back-calculated CD spectrum was above the threshold value 





For vesicle experiments with excess water, negatively charged lipids are needed to assure 
binding of the cationic lipids to the membranes, and therefore PG lipids were included in 
leakage and CD experiments. In solid-state NMR using oriented samples, hydration is low 
and peptides are forced to interact also with neutral membranes.28 To simplify the systems, 
only neutral PC lipids were used in the NMR experiments. 
 
In DOPC, all the labelled peptides gave well-resolved 2H-NMR spectra at the peptide-to-lipid 
molar ratios (P/L) of 1:50 and 1:20, as seen in Figure 3A and B. A central peak can be 
observed in all spectra due to residual deuterium in the water used for hydration. Distinct 
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quadrupolar splittings with high intensity are always present, originating from peptides that 
are uniformly aligned in the membrane, thus providing information about peptide orientation. 
For KIA14-I2A, only a central peak is observed, which might be due to problems with the 
sample, or simply because the splitting is too small to be resolved and overlaps with the 
central peak. Because clear splittings are observed for all the other samples, we assume that 
the splitting is 0 kHz for now. In some spectra, a second doublet with lower intensity is 
observed which has half of the main splitting, but this is of no concern and can be attributed to 
mobile peptides in unoriented regions of the sample.17 All splittings from oriented peptides at 
each labelled position are listed in Table 4. The splittings are very similar at the two 
concentrations, indicating that the peptide orientation remains essentially the same in DOPC. 
For P/L = 1:50, orientational analysis using all 10 data points from positions 2 through 14 
exhibits a bad fit, with a high RMSD of almost 6 kHz. The helical wave plot in Figure 4A 
shows deviations for several data points, and the minima in the τ/ρ and στ/σρ plots in Figure 
4B and C are not well defined. The nominal best-fit tilt angle is τ = 101°, which indicates a 
flat alignment of the peptide on the membrane surface, in agreement with our earlier 15N-
NMR result 14. The azimuthal angle is ρ = 121°, which is also approximately what is 
expected, as this corresponds to the charged lysine face pointing towards the water phase. The 
dynamical parameters are στ = 0° and σρ = 28° (Figure 4C), indicating that the tilt angle of the 
peptide does not fluctuate, while a larger wobble is observed around the helix axis. 
 
The same analysis can now be performed by excluding data from the C-terminal end. When 
the splitting from position 14 is excluded and data from only positions 2-13 are used, the fit is 
only marginally better than that when all the points are used (Table S2). Figure 4A shows 
that the splitting from position 14 fits the curve nicely, indicating that the peptide forms a 
helix all the way to the C-terminus. Only the splitting from position 13 does not fit so well, 
but a removal of the data from positions 13 and 14 does not improve the fit very much (Table 
S3). We also tried to exclude data from both termini by excluding positions 2 and 3, which do 
not appear to be part of the helix, and one data point from the C-terminus, thus only using 
data from positions 4 through 13. Because this fit is no better than that including position 14 
(RMSD = 2.4 kHz), we can conclude that the peptide essentially forms an ideal helix from 
positions 4 through 14. This conclusion is in full agreement with the CD analysis that had 
shown that about 3 peptide bonds in KIA14 are unfolded. 
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2H-NMR spectra of KIA14 labelled at various positions (marked for each row) in different 
lipid systems (marked for each column) at 35°C. The P/L ratio is shown in brackets in each column. 
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Figure 4. Analysis of the 2H-NMR data from KIA14 in DOPC at P/L = 1:50. The left panel in each 
row shows the best-fit helical wave, in which the quadrupole splittings of the Ala-d3 labelled positions 
are plotted along the peptide sequence. The right panel in each row shows the RMSD plots of the 
peptide orientation in terms of τ and ρ, with an inset RMSD plot showing the dynamical parameters στ 
and σρ. (A-C) In the analysis using all 10 labelled positions, the best-fit RMSD is very high. (D-F) 
When excluding the data point from the label at position I2A (open square), a better RMSD is 
obtained, with almost the same helix orientation. (G-I) When excluding positions I2A and A3, the 
RMSD improves further, giving a reliable best-fit orientation of τ = 97° and ρ = 128°. (J-L) By 
excluding positions I2A, A3 and I13A, and even lower RMSD value is obtained, with a best-fit 
orientation of τ = 98° and ρ = 128°.  
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2H-NMR quadrupolar splittings of KIA14 (in kHz). 

















KIA14-I2A 0 0 5.6 4.0 5.1 13.9 13.1 
KIA14-A3 17.7 19.0 13.8 20.2 20.7 23.6 23.9 
KIA14-G4A 43.7 43.7 48.9 49.9 49.7 44.5 39.4 
KIA14-I6A 6.0 7.7 0 0 0 14.5 16.2 
KIA14-A7 8.4 6.7 7.9 8.3 9.4 0 0 
KIA14-I9A 7.8 9.2 0 3.3 0 18.5 18.5 
KIA14-A10 21.3 21.5 22.4 24.1 23.9 23.7 21.0 
KIA14-G11A 39.9 39.0 41.2 35.3 39.4 44.0 26.9 
KIA14-I13A 24.1 25.3 22.2 21.3 22.3 0 0 
KIA14-A14 11.8 12.3 20.2 13.8 14.1 16.4 16.9 
 
The high RMSD is likely due to the peptide being partially unfolded, especially near its 
termini. This can now be investigated in more detail at a residue-specific level by excluding 
some data points close to the termini from the fitting procedure. When the splitting from 
position 2 is excluded from the fit, the quality of the fit improves, giving an RMSD = 3.2 kHz 
(Figure 4D-F), and the τ/ρ/στ/σρ minimum becomes better defined. Clearly, the data point 
from position 2 do not fit the helical wave curve. The resulting helix orientation does not 
change much compared to that observed using all the data points; the tilt angle is slightly 
smaller at 97°, the azimuthal angle changes to 128°, and the dynamics are essentially the 
same. When the data from position 3 is also excluded, the best-fit orientation in terms of τ, ρ, 
στ and σρ is identical, but the RMSD is further improved to 2.4 kHz (Figure 4G-I, Table S1). 
This is a reasonably good RMSD value and similar to that previously found for KIA21.24 
Removing one further data point from position 4 does not improve the fit any more (RMSD = 
2.3 kHz). Thus, it seems that positions 1-3 do not form a helix, but the peptide is helical from 
position 4 onwards. 
 
We must not forget, however, that some of the data points stem from mutated peptides. As 
already suggested by the CD deconvolution, some data may not be useful, especially from 
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KIA14-I2A and KIA14-I13A, since the helicity of these peptides is considerably lower than 
that of KIA14. The data from the N-terminal positions I2A and A3 have already been 
excluded in the 2H-NMR analysis above, but it may also be risky to include the partially 
destabilized KIA14-I13A mutant in the structure analysis. The quadrupole splitting of 
position I13A may well reflect a distorted helix, while KIA14 with an Ala-d3 label at position 
A14 would be perfectly unperturbed. Indeed, we observed that the data point from position 
I13A deviates slightly from the best-fit curve (Figure 4G). If we repeat the analysis after 
excluding positions I2A, A3 and I13A, a much improved fit with an RMSD of 1.4 kHz is 
obtained, while the orientation and dynamics of the peptide are essentially the same; the tilt 
angle here is 98°, and the azimuthal angle is 128° (Figure 4J-K, Table 5). The corresponding 
fits for KIA14 in DOPC at a higher peptide concentration of P/L = 1:20 are shown in 
Supporting Information Figure S1, and the best-fit parameters are listed in Tables 3 and 
S1. The results are almost identical to those at P/L = 1:50. 
 
Table 5. The detailed membrane alignment and dynamical behavior of the amphiphilic helical 
for KIA14 and KIA21 (MSI-103) peptides was obtained by 2H-NMR analysis in various lipid 
systems, giving the best-fit values of the helix tilt angle (τ/°), azimuthal rotation angle (ρ/°), 
whole-body fluctuations of τ (στ/°) and ρ (σρ/°), and the root mean square deviation 
(RMSD/kHz). 







Lipid system P/L τ ρ στ σρ RMSD τ ρ στ σρ RMSD τ ρ στ σρ RMSD 
DOPC 1:50 101 121 0 28 5.7 98 128 0 25 1.4 94 133 0 14 3.2 
DOPC 1:20 101 115 6 26 5.7 96 128 0 22 2.4 93 134 0 13 2.8 
DMPC 1:50 101 123 0 26 5.5 109 124 25 17 2.8 127 100 3 2 3.4 
DMPC 1:20 102 122 7 26 4.9 109 123 22 23 3.5 126 109 0 0 3.8 
DLPC 1:50 101 124 0 25 4.5 105 125 16 23 2.6 123 105 0 18 1.4 
DMPC/lyso-MPC 1:50 146 117 33 13 3.3 148 116 31 15 2.0 135 3 - - - - 
DMPC/lyso-MPC 1:20 163 114 30 2 3.6 163 113 28 9 2.0 - - - - - 
a Using data from all 10 labeled positions in the range of positions 2-14. 
b Excluding data from position I2A, A3 and I13A, except for the lyso-MPC systems where only a 
single data point from position I13A was excluded. 
c Data from ref. 24. No 2H-NMR data is available for KIA21 in DMPC/lyso-MPC systems. But from 
15N-NMR data the peptide is proposed to be transmembrane in DMPC/lyso-MPC (2:1) and a tilt angle 
can be estimated at 1:50 from the 15N chemical shift.14 
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The best-fit orientation of KIA14 in DOPC (using data from the folded positions 4-14, except 
for the partially destabilized Ile13 mutant) and the best-fit orientation of the longer version of 
the peptide KIA21 24 are essentially identical (Table 5). The tilt angle τ of KIA14 is 3° larger, 
which is likely within the error of the method. The azimuthal angle ρ is 5-6° smaller in 
KIA14, but inspection of their helical wheels shows that the center of the polar sector is 
shifted 10° clockwise in KIA14 compared to that in KIA21 (see arrows in Figure 1). Since 
the observed difference in ρ corresponds to the same direction, the observed decrease of 5-6° 
in ρ for KIA14 means that its polar sector is aligned in very much the same way as in KIA21. 
The shorter peptide appears slightly more dynamic, as the σρ value is 10° larger. The result is 
the same for both KIA21 and KIA14 at P/L = 1:50 and 1:20. A flat orientation of KIA21 on 
the membrane surface has been observed in a wide range of unsaturated lipid systems,24 and is 
typical for amphipathic peptides in lipid systems with negative spontaneous curvature.25,54 
 
In DMPC at P/L = 1:50, all samples gave clear splittings (Figure 3C), and a fit using all of 
the data points yields an orientation very similar to that of KIA14 in DOPC. Again, the 
RMSD in DMPC at P/L = 1:50 is unacceptably large (> 5 kHz) (Figure 5A-C). Excluding 
positions I2A and A3 from the fit results in a better RMSD (3.8 kHz), with a best-fit 
orientation of τ = 103° and ρ = 124°, and best-fit dynamical parameters of στ = 18° and σρ = 
17° (Table S1). These values indicate larger fluctuations of the tilt angle in DMPC compared 
to DOPC, while the rotational fluctuations around the helix axis are similar in both lipid 
systems. After further excluding positions I13A and/or A14 (Tables S2-S4), we found once 
again that removing position A14 did not improve the fit. Thus, we can conclude that the 
peptide is also essentially helical for positions 4-14 in DMPC. However, excluding position 
I13A results in a better fit, with an RMSD of 2.8 kHz, corresponding to τ = 109°, ρ = 124°, στ 
= 25°, and σρ = 17°. 
 
At a high peptide concentration of P/L = 1:20, the spectra in DMPC do not show as clearly 
defined peaks as at 1:50 (Figure 3D), though the splittings are similar to those at 1:50 
(usually within 2 kHz, but in some cases the difference is larger). For labels at positions A3, 
A7 and A10, a second splitting of 37 kHz is evident, which is typical of aggregated peptides 
that have become immobilized and unoriented. The same behaviour has also been reported for 
KIA21 in DMPC/cholesterol.24 When the splittings from the oriented peptides are fitted, 
essentially the same results as for DMPC at 1:50 is obtained (Figure S2 and Table 5). Again, 
Page 19 of 37
ACS Paragon Plus Environment































































fitting of all data points gives a bad fit, but excluding positions I2A, A3 and I13A yields a 
good fit, with an RMSD of 3.5 kHz, corresponding to τ = 109°, ρ = 123°, στ = 22°, and σρ = 
23°. The orientation is within 1° from that found at 1:50, which is within the error of the 
method, and the dynamic parameters are also very similar. As in DOPC, almost no change in 
the orientation or the dynamics was observed upon increasing the peptide concentration from 
1:50 to 1:20. 
Figure 5. 2H-NMR data analysis of KIA14 in DMPC at P/L = 1:50, analogous to Figure 4. (A-C) In 
the analysis using all 10 labelled positions, the best-fit RMSD is very high. (D-F) When excluding 
data from labels at positions I2A, A3 and I13A, a low RMSD value is obtained, with a best-fit helix 
orientation of τ = 109° and ρ = 124°.  
 
Also in DLPC at P/L = 1:50, there are clean splittings (Figure 3E) that are very similar to 
those in DMPC at P/L = 1:20. A fit using all the data points results in an orientation very 
similar to that of KIA14 in DMPC, with a high RMSD of 4.5 kHz. The fits are shown in 
Figure S3. Again, excluding positions I2A and A3 provided a better fit, and excluding 
position I13A improved the RMSD to 2.6 kHz. The orientation in this case is τ = 105° and ρ = 
125°, which is very similar to those in DMPC and DLPC. The same correspondence was also 
previously observed for KIA21 in DLPC.24 
 
Interestingly, the picture changes when moving to DMPC/lyso-MPC at P/L = 1:50 and P/L = 
1:20. All spectra gave clear splittings (Figure 3F and 3G), but they look quite different from 
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those observed in the other lipid systems, e.g. at positions I2A and A7 (Figure 3, Table 4), 
which immediately suggests that the orientation is different. A fit using all ten data points at 
P/L = 1:50 gave τ = 146° and ρ = 117°. Here, the RMSD is 3.3 kHz, which is considerably 
better than that for the other lipid systems examined above, and as good as those of the other 
lipid systems after positions I2A and A3 had been excluded. The fit (Figure 6A) shows that 
only position I13A does not fit the curve. In this case, excluding positions I2A and A3 from 
the fit only results in a very slight reduction of RMSD to 3.2 kHz, which is not a convincing 
argument to exclude these two N-terminal data points. Removing the C-terminal position A14 
also has little effect. Only when position I13A is excluded, the RMSD goes down to 2.0 kHz, 
with τ = 148° and ρ = 116°. These findings indicate that the whole peptide from position 2-14 
forms an ideal helix in DMPC/lyso-MPC. Only in KIA14-A13A, the splitting does not fit the 
helical curve, indicating that this mutation perturbs the structure, as already suggested by CD 
and as seen in the other lipid systems, too. Interestingly, the helix tilt angle observed here for 
KIA14 in DMPC/lyso-MPC is 148°, which corresponds to a more upright orientation, where 
the helix axis is inclined by only about 30° away from the membrane normal. This structure is 
in stark contrasts to the helix orientation observed in the other studied lipid systems, in which 
the peptide is aligned nearly flat on the membrane surface. The upright orientation in 
DMPC/lyso-MPC also fits with previous 15N-NMR data in this lipid mixture 14. The ρ angle is 
decreased by about 10° compared to the value observed for the other systems. The dynamical 
parameters are στ = 31° and σρ = 15°, indicating that the fluctuations of the tilt angle are larger 
in DMPC/lyso-MPC than in pure DMPC, while the fluctuations around the helix axis are 
similar. 
 
In DMPC/lyso-MPC at a high peptide concentration of P/L = 1:20, the splittings look quite 
similar to those at 1:50, with KIA14-G4A and KIA14-G11A being notable exceptions. When 
all data are analysed together, a rather poor fit is obtained, as the RMSD is 3.6 kHz. If 
positions I2A and A3 are excluded, the fit does not improve. When position I13A is excluded, 
however, the RMSD is reduced to 2.0 kHz, which is a good fit (Figure S4). All calculations 
yield essentially the same helix orientation of τ = 163° and ρ = 113°, whether all data points 
are included, whether positions I2A and A3 are excluded, or whether position I13A is 
excluded. The tilt angle describes a very upright helix orientation, as the peptide axis is only 
inclined by 17° away from the membrane normal. In this lipid system, we have thus found a 
clear change in helix orientation with peptide concentration: the tilt angle changes from 148° 
at P/L = 1:50 to 163° at P/L = 1:20. This observation is significant, even though the error 
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margin in this lipid system is larger, as seen in Figure 6C, making a range of tilt angles 
compatible with a low RMSD. 
 
 
Figure 6. 2H-NMR data analysis of KIA14 in DMPC/lyso-MPC (2:1) at P/L = 1:50, analogous to 
Figures 4 and 5. (A-C) A fit using all 10 labelled positions gives a resonable RMSD. (D-F) Excluding 
the data from position I13A gives a good RMSD value, with a best-fit helix orientation of τ = 148° and 
ρ = 116°.  
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In this study, we determined the membrane orientation of the amphipathic α-helical peptide 
KIA14 in different lipid bilayers, paying particular attention to helix fraying at the termini. It 
is highly informative to compare the structural behaviour of this short sequence with previous 




To examine the local helicity of an amphipathic α-helix bound to a membrane, we used solid-
state 2H-NMR in macroscopically oriented lipid samples, which provides anisotropic local 
information on specifically labelled segments of a peptide. 2H-NMR was chosen rather than 
15N-NMR55-57 or 13C-NMR58-59 – solid-state nuclei which can be used to get similar 
information – in this study, since we have previously studied the longer KIA21 peptides 
extensively with 2H-NMR23-24, and also wanted to investigate the effect of Ala mutations on 
the structure and orientation of the peptides. 
  
In solutions, a more straightforward NMR approach to look at helix fraying has been  used, 
given that the isotropic 13C chemical shift reflects the local secondary structure. Ala-rich 
model peptides had been specifically labelled with 13C=O in the backbone, and their helicity 
was studied as a function of temperature and solvent.60-61 In those publications, the central 
region of these peptides was found to be most persistently helical. A gradual decrease of 
helicity towards both termini was observed, with variations due to the sequence, which 
reflects a dynamical opening and closing of hydrogen bonds within the peptide backbone and 
towards the aqueous solvent.60-61 A different behaviour may be expected for membrane-bound 
peptides, because the hydrophobic lipid environment is known to stabilize intramolecular 
hydrogen bonding. Indeed, the KIA14 peptide is by no means helical but completely 
disordered in aqueous solution, and it only forms a helix upon binding to a membrane (or 
micelle or TFE/H2O mixture, data not shown). In the present work, we thus studied the local 
helicity of a membrane-bound helix to get some original insights into protein folding under 
these conditions.  
 
In many previous solid-state NMR studies of membrane-bound peptides, only the central 
stretch of the peptide was labelled, and positions close to the termini were avoided for good 
reasons.2,5,17-19,23-24,50,62 Those precautions made it possible to analyse the anisotropic NMR 
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parameters while assuming an ideal α-helix or β-sheet, which was indeed confirmed to be a 
good approximation for the central region of the peptides in those cases. Obviously, the labels 
in the middle of the peptide could not provide any information regarding possible fraying of 
the termini. In some cases Ala residues close to the termini were labeled with Ala-d3 in 
peptides from the GWALP family.15,30 In GWALP23, splittings from position 3 and 21 did 
not fit the helical curve from the core region, indicating helix unwinding at both termini in the 
23-mer peptide.30 In A4,5GWALP23 and F4,5GWALP23, a more thorough study was done of 
terminal fraying, and it was proposed that the fraying could be a critical stabilizing factor to 
define the orientation and structure of the transmembrane helix, and also limit its dynamics.15 
Here, we replaced all residues in the KIA14 sequence with Ala-d3, except for the charged 
lysines. This virtually complete set of labels yielded data from positions 2-14 along the entire 
peptide, including positions close to the termini. 
 
When folded as an α-helix, KIA14 has an amphipathic structure with bulky hydrophobic Ile 
residues and positively charged Lys resides protruding on opposite faces, and small Ala and 
Gly residues in between. The sequence can be written as KIAGKIAKIAGKIA to highlight the 
charged residues (underlined), the strongly hydrophobic residues (bold) and the small residues 
(italics). This annotation shows the periodicity of the three classes of amino acid residues (see 
also Figure 1). If we now replace Ile-13 with Ala, the sequence becomes 
KIAGKIAKIAGKAA, which carries no large hydrophobic residue after Ile-9, hence the five 
remaining C-terminal residues should be less likely to form an amphipathic helix. This 
expected behaviour can indeed be observed by CD, where KIA14-I13A shows a much lower 
helicity than KIA14. In addition, we notice in the helical wave curves that the NMR splitting 
from KIA14-14A, which has exactly the same sequence as KIA14, fits to the helical curve 
very well, indicating that this peptide forms an essentially ideal helix all the way to the C-
terminus, including Ile-13. However, the splitting from the mutant KIA14-I13A does not fit 
the helical wave, indicating that the helicity is lower for this peptide, which must have started 
to unfold at the C-terminus. From these data, we can conclude that the original KIA14 peptide 
forms an essentially ideal helix all the way up to the C-terminus, whereas the KIA14-I13A 
mutant is less helical in the C-terminal region. 
 
Likewise, when we replace Ile-2 with Ala-d3, the sequence changes to KAAGKIAKIAGKIA. 
In this sequence, there is no highly hydrophobic residue in the N-terminal region up to Ile-6, 
as the first five residues are all charged or small. Thus, the amphipathicity of this segment is 
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much lower now, hence this region may potentially not bind to the membrane and/or not form 
a helix. Indeed, the CD results (Table 3) show that the mutant KIA14-I2A is less helical 
(43%) than KIA14 itself (76%), and the 2H-NMR splitting from KIA14-I2A does not fit the 
helical wave curve. The labelled KIA14-A3 has the same sequence as the original peptide, 
and therefore the same helicity, but its splitting does not fit the helical wave curve. Therefore, 
we can conclude that this residue Ala-3 is disordered, and that the N-terminus of KIA14 must 
be frayed out. For the next label in KIA14-G4A, on the other hand, the splitting fits well to 
the helical wave curve, and so do all other (non-perturbing) labels on the peptide from this 
position onwards. The CD results show a helicity of 76%, indicating that out of all 14 amino 
acids (i.e. 13 peptide bonds), a total of about 10 peptide bonds participate in the helical 
conformation. Because this CD estimate fits very well with the NMR data, we can conclude 
that the KIA14 peptide is α-helical from position 4 through to 14 (Figure 7).  
 
Our NMR data clearly show that Ile-2 is not part of the helix in the original KIA14 peptide. 
Obviously, position 2 is also not contained in the helical region of the KIA14-I2A mutant, in 
which the helicity is reduced to 43% according to CD, which corresponds to only 5-6 peptide 
bonds. These observations suggest that the helical segment in KIA14-I2A spans only from 
Ile-9 through to Ala-14, meaning that the entire N-terminal half of the peptide has lost its 
helicity and started to unravel when Ile-2 is replaced with Ala. Likewise, in the KIA14-I13A 
mutant we observed a helicity of only 45%, indicating that only six peptide bonds are in a 
helical conformation. If we assume that the I13A mutation has little effect on the N-terminus, 
the helix would begin (as in the original peptide) at position 4 and extend up to Ile-9. 
Mutating Ile-13 to Ala should thus result in the five C-terminal residues (AGKAA) being non-
helical and frayed out. The tentative helical parts of these peptides are shown in Figure 7. 
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Figure 7. Folding of KIA14 and some of its mutants in the membrane-bound state, as determined from 
2H-NMR and CD. The sequence marked in red forms an α-helix, also shown in red. The peptide 
backbone is drawn in black, with an orange box representing the membrane. The large, hydrophobic 
Ile residues are marked with yellow circles. For KIA14 the picture is based on CD and all 2H-NMR 
data. For the I2A and I13A mutants the picture is based on CD and a single 2H-NMR data point, and is 
therefore more tentative, as discussed in the text. 
 
The picture is not as clear-cut for the two central Ile residues, Ile-6 and Ile-9. Both mutants 
KIA14-I6A and KIA14-I9A are less helical than KIA14 according to CD (42% and 50%, 
respectively), but the 2H-NMR splittings from the mutants fit perfectly to the helical curve, 
indicating that these positions are still part of the helix. A plausible explanation for these 
seemingly contradictory observations would be that these less hydrophobic mutants have a 
reduced overall binding affinity to the membrane, given that one of their central anchoring Ile 
residues is missing. As a consequence, a smaller fraction of the peptides would bind to the 
vesicles in the CD experiments, which are carried out in a vast excess of aqueous solvent. In 
this case, the observed average helicity would be reduced, because only those peptide 
molecules that are bound to the membrane would contribute to the helical CD signal, while 
the unbound peptides remain disordered in solution. This possibility seems quite likely under 
CD conditions, even though we had mixed some anionic DMPG lipids into the small 
unilamellar DMPC vesicles to attract the peptides electrostatically. In contrast, there is no 
excess bulk water present in the NMR samples, which are prepared just under saturating 
hydration conditions. In these multilayer samples, all peptides are forced to bind to the 
membrane, as previously demonstrated.28 Altogether, we can conclude from the combination 
of CD and NMR that Ile-2 is not part of the helix in KIA14, that Ile-13 is necessary for the 
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helix to extend all the way to the C-terminus, and that all Ile residues are important for the 
formation of a membrane-bound helix. 
 
These results fit nicely with those of a previous study, in which two analogues of KIA14 were 
used that contained two additional Lys residues.36 In this KIA(7)14 mutant 
[KKAGKIAKKAGKIA-NH2], Ile-2 and Ile-8 were replaced by Lys, and this peptide was not 
helical at all. It only exhibited 3% helicity in the presence of DMPC/DMPG vesicles 
according to the deconvoluted CD spectra, indicating that the peptide was not bound to the 
membrane. In contrast, the mutant KIKA14 [KIAKKIAKIAKKIA-NH2], in which Gly-4 and 
Gly-11 were replaced with Lys but all four Ile residues were retained, showed 80% helicity, 
which was similar to that of the original KIA14.36 We can thus conclude that for KIA14 the 
large hydrophobic Ile residues are crucial for its ability to bind to and form an amphipathic α-
helix in the membrane. 
 
From the vesicle leakage assays, we find a strong correlation between peptide helicity and the 
ability to induce leakage in DMoPC/DMoPG vesicles (which have short acyl chains). The 
peptides with Ile→Ala-d3 mutations, which had a reduced helicity of only 40-52%, gave only 
a fraction of the leakage found for KIA14, while the Gly→Ala-d3 mutants had a higher 
helicity and stronger leakage. We have previously proposed that peptides of the KIA series 
must be long enough to span the hydrophobic core of the membrane in order to form pores 
and induce leakage.13,36 Here, we see clearly that when the peptides are not helical, their 
effective length in the membrane is reduced, as unordered parts are probably not interacting in 
a stable manner with the membrane. Notably, the KIA(7)14 peptide mentioned above, with 
almost no helicity, did not induce any leakage in DMoPC/DMoPG vesicles.36  
 
In any peptide, the full hydrogen-bonded pattern of an α-helix necessarily remains incomplete 
at both termini, because H-bonds cannot extend beyond the backbone. Interestingly, 
according to our results, the C-terminus of KIA14 forms a much more stable helix than the N-
terminus, even though their amino acid sequences are almost identical. This may be due to the 
fact that the C-terminal region is more hydrophobic (no charge at the amidated C-terminus) 
and can therefore bind better to and insert more deeply into the membrane. In addition, we 
found that in the presence of lyso-lipids, where the entire peptide is inserted more upright in 
the membrane, the N-terminal region also becomes more helical, as the splittings from 
positions 2 and 3 now also fit the helical wave curve (Figure 6A). This effect may probably 
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be attributed to the assembly of an oligomeric pore, in which a completely folded and well-
structured helical peptide is required to span the hydrophobic membrane core.13-14 
 
In a few, very thorough solid-state 19F-NMR studies, peptides had also been labelled close to 
the termini. The cell-penetrating peptide transportan 10 (TP10) was labelled selectively in 
several places from position 2 to the C-terminal position 21.16. In this case, the N-terminal 
region (residues 1-8) did not form an α-helix, and there was no sign of helix fraying at the C-
terminus.The short 11-amino acid multifunctional peptide BP100 63 was labelled with 19F-
containing amino acids .39 or Ala-d3, 20 and no fraying was observed at either terminus.  
 
BP100 does not contain any Gly residues in its sequence, and CD analysis showed BP100 to 
have a remarkably high α-helix content of about 61%. The peptide TP10, on the other hand, 
has two Gly residues in its unstructured N-terminal region, but none in its well folded α-
helical C-terminal region. Also the peptide of our present interest, KIA14, contains two Gly 
residues, and replacing them with Ala-d3 increased the helicity. Thus, it appears fully 
plausible that α-helices without Gly (or Pro, a very strong helix breaker) are more rigid and do 
not fray as much at their termini due to their continuous H-bonding pattern.  
 
Lipid-dependent helix orientation 
For cationic amphipathic peptides, with one charged face and one hydrophobic face, the most 
straightforward orientation in a lipid membrane is flat on the membrane surface (τ ≈ 90°), 
with the polar part pointing up to the water phase, and the hydrophobic part pointing into the 
hydrophobic membrane interior (Figure 8A, left). This is the orientation expected and 
observed for all peptide studied so far at low P/L, where the peptides are monomeric. At 
higher peptide concentration, it has been proposed that peptides can form discrete dimers with 
an oblique tilt angle (τ ≈ 120°) (Figure 8A, middle). At even higher concentrations, under 
suitable conditions, the peptides can insert further into the membrane as a multimeric pore 
with a more or less upright, transmembrane orientation (τ ≈ 180°) (Figure 8A, right). The 
polar residues of the peptides line the aqueous channel, while the hydrophobic ones are 
anchored in the surrounding lipid bilayer. As there is a dynamical equilibrium between the 
three states in the membrane, it is important to note that - depending on the conditions - one or 
the other state will dominate, and the overall time-average amongst them will usually be 
observed as an angle in the solid-state NMR experiment. 
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It is generally known that the membrane orientation of amphipathic helical peptides is 
strongly influenced by the lipid composition. In particular, we had found that the lipid 
spontaneous curvature appears to be a key factor.54 In lipids with a negative spontaneous 
curvature, such as DOPC, peptides are always observed to lie flat on the membrane 
surface,14,20,24-25,54 and this was also found for KIA14 in DOPC in the present study, and 
previously for KIA21 (Figure 8B).24 
 
 
Figure 8. (A) Orientational states of cationic amphipathic helical peptides. Left: As a monomer the 
peptide is lying almost flat on the membrane surface. Middle: With increasing peptide concentration 
the tilt angle increases to around 125°, corresponding to a discrete postulated dimer. Right: The 
peptides can also assemble further into a multimeric pore with the helices in a transmembrane 
orientation with a more or less upright alignment. (B) Orientation of KIA14 and KIA21 in a 
membrane, as determined from 2H-NMR. The tilt angle is shown in each case. (For simplicity only 
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one peptide is shown in each case, even if peptides are proposed to form dimers or pores.)  
* The orientation of KIA21 in DMPC/lyso-MPC at 1:50 is estimated from 15N-NMR data;14 
** at 1:20 the orientation is estimated to be the same as at 1:50, based on the orientation in other lipid 
systems not changing between 1:50 and 1:20.  
 
In lipids with a low positive spontaneous curvature such as DMPC and DLPC, on the other 
hand, some peptides stay flat on the surface, while others are able to insert more deeply into 
the membrane. Now, we can compare the behaviour the short KIA14 with its longer analogue 
KIA21. In both DMPC and DLPC, the longer peptide exists in a tilted state with a tilt angle of 
approximately 125°, while KIA14 peptide is only slightly tilted (tilt angle of approximately 
105°) (Figure 8B). This difference cannot be explained by a change in the mean 
hydrophobicity of the peptides, by different residues close to the C-terminus (which is 
inserted deeper into the membrane than the N-terminus), nor by a change in the polar sector 
size (Figure 1), because these properties are exactly the same for both peptides. Yet, it seems 
likely that longer peptides would engage in stronger peptide-lipid interactions, and obviously 
also cover a larger surface area due to their size. Therefore, peptide-peptide interactions in the 
membrane should also be enhanced in the case of KIA21 compared to KIA14, because the 
larger peptides are on average closer to each other at the same P/L ratio. We found that 
KIA21 is already strongly tilted at a moderate peptide concentration of 1:50, whereas KIA14 
is only slightly tilted at a high concentration 1:20. Therefore, this difference cannot be solely 
attributed to a crowding effect. We have also noted by NMR that KIA14 is more mobile than 
KIA21 (Table 5), which is expected for a shorter peptide. This difference is especially large 
in DMPC, which may indicate that the surface-aligned KIA14 is monomeric, while the tilted 
KIA21 forms dimers or higher oligomers, aspreviously postulated for the 21-mer PGLa in 
membranes.19,28,50 
 
As mentioned above, in bacterial assays, KIA14 shows no antimicrobial activity, which is 
likely due to this peptide being too short to span the bacterial membrane and therefore being 
unable to form a pore.13 The length of KIA14 as an ideal helix is 21 Å, which is less than the 
hydrophobic thickness of DMPC of 25.4 Å, though similar to the hydrophobic thickness of 
DLPC of 20.9 Å.64 We found that the peptides which are not inserted in these lipid systems do 
not appear to be fully helical, as only a 76% helicity was observed according to CD (Table 3). 
Thus, the folded core of KIA14 would probably be shorter than 21 Å, and therefore not long 
enough to span the pure DLPC bilayers.  
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In DMPC bilayers containing lyso-PC lipids, which have a highly positive spontaneous 
curvature,65 insertion into a transmembrane state is promoted, and pores are easily formed. 
Even the short KIA14 peptide can become inserted now, with a very steep tilt angle, which 
indicates that the lyso-lipids lead to local membrane thinning such that the peptides are able to 
span the membrane in this case. This ability to insert almost upright had been previously 
shown by 15N-NMR,14 and was confirmed here with high accuracy using 2H-NMR, which 
revealed also the corresponding azimuthal rotation ρ and dynamical parameters στ and σρ. 
Because KIA14 carries several charged residues on one face, it is unlikely to span the 
membrane as a monomer, so the highly tilted state must correspond to an oligomeric 
transmembrane pore, as previously discussed.14 In our earlier 15N-NMR study, KIA21 was 
also found to be inserted in DMPC/lyso-MPC in a transmembrane orientation, as was the 
whole series of KIA-type peptides that were 14 to 28 amino acids in length. Their helix tilt 
angle was seen to change gradually, with KIA14 being the most upright, and with increasing 
helix length the peptides tilted more and more away from the membrane normal. This way, 
they could adapt their individual effective hydrophobic length to the membrane thickness in a 
mismatch-dependent manner.14 The concept of hydrophobic matching had been observed and 
discussed so far only for completely hydrophobic segments of peptides and integral proteins,66 
but clearly holds also for amphiphilic peptides. 
 
Finally, we can now compare the different types of model lipid systems in terms of their 
suitability to detect re-alignment events of membrane-active peptides, which are often found 
to be concentration-dependent and indicative of oligomerization and/or pore formation (Table 
3). In DOPC and DMPC, the orientation of KIA14 (in the form of flat monomers, and 
obliquely tilted dimers, respectively) did not change upon increasing the peptide 
concentration from P/L = 1:50 to 1:20. On the other hand, in DMPC/lyso-MPC the short 
KIA14 helix was steeply inserted (and hardly frayed out), and it showed a concentration-
dependent change in tilt angle of 15°. Similarly, in a previous study of the longer KIA21 
peptide (called MSI), no concentration dependence was observed in DOPC or DMPC between 
P/L = 1:50 and 1:20.24  
 
To summarize these observations on lipid dependence: in extreme cases, in which the lipids 
have a highly positive or negative spontaneous curvature, the helix orientation and oligomeric 
state appears to be determined mostly by the lipids. We therefore propose that lipids with a 
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spontaneous curvature close to zero, like DMPC and DLPC, are  more suitable lipid systems 
in which the more subtle effects of peptide modifications should be compared, e.g. how 
mutations, charge, hydrophobicity, or peptide length influence the ability of amphipathic 
peptides to be inserted into membranes. Under these conditions, it might be possible to screen 
for the most strongly membranolytic antimicrobial and/or cytotoxic peptides.  
 
Conclusions 
CD and solid-state NMR are used here as complementary methods to study the global and 
local helicity of the membrane-bound amphipathic peptide KIA14. The methods agree well 
and give information about the fraying at the peptide termini. KIA14 forms an essentially 
ideal helix from residue 4 to 14. When Gly residues are mutated to Ala, the helicity increases. 
On the other hand, when Ile residues are mutated to Ala, the helicity is dramatically reduced. 
This indicates that the hydrophobic Ile side chain is needed to anchor the peptide to the 
membrane and when they are removed the peptide is partially unbound and loses locally its 
helical structure. This loss of helicity also leads to a loss of activity, as seen by a reduced 
ability to induce leakage of vesicles. The orientation of KIA14 is the same as that of the 
longer KIA21 peptide in DOPC bilayers, where both peptides are lying flat on the membrane 
surface. In DMPC/lyso-MPC lipids, both peptides are inserted into a membrane-spanning 
orientation, with a tilt angle which depends on hydrophobic matching. In DMPC and DLPC, 
there is a difference between the orientation of the two peptides, and the shorter KIA14 is 
more flat on the surface, whereas the longer KIA21 is found in a tilted state. This difference is 
likely due to stronger peptide-peptide interactions between the longer peptides. 
 
Supporting information 
The Supporting Information is available … 
Tables describing results of fits of 2H-NMR data using different sets of data points (Tables 
S1-S4). Best-fit analysis in DOPC at P/L=1:20 (Fig. S1), in DMPC at 1:20 (Fig. S2), in DLPC 
at P/L=1:50 (Fig. S3) and in DMPC/lyso-MPC at P/L=1:20 (Fig. S4). 
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